Premium
Diplopia from peribulbar ropivicaine
Author(s) -
Wells Anthony P,
Maslin Keith
Publication year - 2000
Publication title -
clinical and experimental ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.3
H-Index - 74
eISSN - 1442-9071
pISSN - 1442-6404
DOI - 10.1046/j.1442-9071.2000.00250.x
Subject(s) - diplopia , medicine , anesthesia , surgery , cataract extraction , eye disease , general anaesthesia , ophthalmology
Purpose : To report a previously undescribed side‐effect of ropivicaine (Naropin) used in peribulbar anaesthesia. Methods : We report nine cases identified prospectively with symptomatic diplopia, predominantly vertical, following Ropivicaine use for peribulbar anaesthesia in routine cataract surgery. These nine cases occurred in a 10‐week period from a total of 77 patients given 7 mL peribulbar ropivicaine (10 mg/mL) with 750 units hyalase prior to cataract extraction by a single surgical team. Results : None of the cases had preoperative ocular motility disturbances and none had superior rectus traction sutures. All diplopia resolved in less than 30 h. Conclusions : Ropivicaine may have a prolonged motor block resulting in diplopia of up to 30 h duration after peribulbar anaesthesia.